November 4, 2021

Regenstrief data experts contribute to NEJM, CDC COVID-19 papers

Regenstrief Institute data experts are actively working to further the understanding of COVID-19 through real-world data. In the last week, the Regenstrief chief executive officer and a vice president have been lead authors on papers published in the U.S. Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR).

Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., is first author on a study analyzing the vaccine effectiveness for  people who are immunocompromised, which is published in the MMWR. Vice President for Data and Analytics Shaun Grannis, M.D., M.S., is the first author on a paper about the effectiveness of COVID-19 vaccines  against the Delta variant, also published in the MMWR. He made significant contributions to a paper on vaccine effectiveness in the New England Journal of Medicine and another paper in the MMWR comparing immunity provided by vaccinations to immunity provided by prior infection.

The papers, in order of publication, and list of Regenstrief authors, are:

These studies are all work of the CDC’s VISION Network, which is made up of seven organizations across the country — including Regenstrief — that submit real-world data for analysis.

About Peter Embí, M.D., M.S. 

In addition to serving as the president and CEO of Regenstrief Institute, Peter Embí, M.D., M.S. is the Leonard Betley Professor of Medicine and associate dean for informatics and health services research at Indiana University School of Medicine, associate director of informatics with Indiana Clinical and Translational Sciences Institute and vice president for Learning Health Systems with Indiana University Health.

About Shaun Grannis, M.D., M.S. 

In addition to his role as the vice president of data and analytics at Regenstrief Institute, Shaun Grannis, M.D., M.S., is the Regenstrief Chair in Medical Informatics and a professor of family medicine at Indiana University School of Medicine.

Related News

LOINC Version 2.77 - Now Available Worldwide

New LOINC® semiannual release highlights health equity projects with national and international partners

LOINC® from Regenstrief Institute’s semiannual content update highlights the comprehensive nature of its work with international partners, including supporting

Rachel Patzer, PhD

Effect of a Novel Multicomponent Intervention to Improve Patient Access to Kidney Transplant and Living Kidney Donation: The EnAKT LKD Cluster Randomized Clinical Trial 

Published in Jama Internal Medicine. Here is a link to the article.  Regenstrief Institute authors: Rachel Patzer, PhD  Abstract 

Tom Imperiale, M.D. and Eleazar Montalvan-Sanchez, M.D.

Stemming colorectal cancer in Latin America

Study analyzes colorectal cancer screening strategies throughout Latin America INDIANAPOLIS – Little is known about colorectal cancer screening strategies